Skip to main content
letter
. 2003 Jan;47(1):440–441. doi: 10.1128/AAC.47.1.440-441.2003

TABLE 1.

Fluoroquinolone activity with clinical isolates of S. pneumoniaea

Compound MIC90 MPC50b MPC90b Cmax Half-life (h) Time > MPC50b,c Time > MPC90b,c AUC0-24/MIC90c Cmax/MIC90c
Gemifloxacin 0.03-0.063 0.25 1 1.6 7-8 14 4 140-280 27-53
Moxifloxacin 0.25 0.5 2 4.5 12-14 24 18 190 18
Gatifloxacin 0.5 1 4 4.2 8-10 12 1-2 103 8.4
Levofloxacin 1 2 8 5.7 5-7 9 0 48 5.7
a

Of the 146 isolates tested, 43 were nonsusceptible to penicillin. Fluoroquinolone susceptibility was unaffected by loss of susceptibility to penicillin. Test cultures, growing in liquid medium, were prepared from bacterial lawns grown directly from frozen samples (2). All concentrations in the table are in milligrams per liter, and times are in hours. (Some of these data were previously reported [2].)

b

Data taken as MPC were designated provisional in previous work (MPCpr) because a twofold overestimate arises from the high inoculum used (>1010 cells per plate). MPCpr is a conservative estimate of MPC.

c

Pharmacokinetic parameters were calculated by using total drug concentration. Cmax applies to doses recommended by the manufacturer (listed in reference 3). AUC0-24, area under the concentration-tin curve from 0 to 24 h.